🇺🇸 FDA
Patent

US 10632209

ASH1L inhibitors and methods of treatment therewith

granted A61KA61K31/404A61K31/454

Quick answer

US patent 10632209 (ASH1L inhibitors and methods of treatment therewith) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Apr 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/404, A61K31/454, A61K31/4545, A61K38/45